Pieter L. Jager
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pieter L. Jager has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Siert Knollema
Department of Nuclear Medicine, Isala, Zwolle, the Netherlands
9 shared publications - Cornelis H. Slump
Robotics And Mechatronics group, University of Twente, Enschede, The Netherlands
6 shared publications - Mohamed Mouden
Departments of Cardiology, Isala hospital, Dr. Van Heesweg 2, 8025 AB, Zwolle, The Netherlands.
6 shared publications - Ad. H. J. Oostdijk
Department of Nuclear Medicine, Isala, Zwolle, the Netherlands
5 shared publications - Jorn A. van Dalen
Department of Medical Physics, Isala, Zwolle, the Netherlands
5 shared publications - Jan Paul Ottervanger
Department of Cardiology, Isala, Zwolle, The Netherlands
4 shared publications
Latest Publications
- Open Access
- 10 December 2019
- Published by Springer Nature in EJNMMI Research
- Vol. 9 (1) , 1-8
SUV variability in EARL-accredited conventional and digital PET
Background: A high SUV-reproducibility is crucial when different PET scanners are in use. We evaluated the SUV variability in whole-body FDG-PET scans of patients with suspected or proven cancer using an EARL-accredited conventional and digital PET scanner. In a head-to-head comparison we studied images of 50 patients acquired on a conventional scanner (cPET, Ingenuity TF PET/CT, Philips) and compared them with images acquired on a digital scanner (dPET, Vereos PET/CT, Philips). The PET scanning order was randomised and EARL-compatible reconstructions were applied. We measured SUVmean, SUVpeak, SUVmax and lesion diameter in up to 5 FDG-positive lesions per patient. The relative difference ΔSUV between cPET and dPET was calculated for each SUV-parameter. Furthermore, we calculated repeatability coefficients, reflecting the 95% confidence interval of ΔSUV. Results: We included 128 lesions with an average size of 19 ± 14 mm. Average ΔSUVs were 6-8% with dPET values being higher for all three SUV-parameters (p < 0.001). ΔSUVmax was significantly higher than ΔSUVmean (8% vs. 6%, p = 0.002) and than ΔSUVpeak (8% vs. 7%, p = 0.03). Repeatability coefficients across individual lesions were 27% (ΔSUVmean and ΔSUVpeak) and 33% (ΔSUVmax) (p < 0.001). Conclusions: With EARL-accredited conventional and digital PET, we found a limited SUV variability with average differences up to 8%. Furthermore, only a limited number of lesions showed a SUV difference of more than 30%. These findings indicate that EARL standardisation works. Trial registration: This prospective study was registered on the 31th of October 2017 at ClinicalTrials.cov. URL: https://clinicaltrials.gov/ct2/show/NCT03457506?id=03457506&rank=1.
- 10 December 2019
- Published by Springer Nature in EJNMMI Research
- Vol. 9 (1) , 1-8
Open AccessSUV variability in EARL-accredited conventional and digital PET
Background: A high SUV-reproducibility is crucial when different PET scanners are in use. We evaluated the SUV variability in whole-body FDG-PET scans of patients with suspected or proven cancer using an EARL-accredited conventional and digital PET scanner. In a head-to-head comparison we studied images of 50 patients acquired on a conventional scanner (cPET, Ingenuity TF PET/CT, Philips) and compared them with images acquired on a digital scanner (dPET, Vereos PET/CT, Philips). The PET scanning order was randomised and EARL-compatible reconstructions were applied. We measured SUVmean, SUVpeak, SUVmax and lesion diameter in up to 5 FDG-positive lesions per patient. The relative difference ΔSUV between cPET and dPET was calculated for each SUV-parameter. Furthermore, we calculated repeatability coefficients, reflecting the 95% confidence interval of ΔSUV. Results: We included 128 lesions with an average size of 19 ± 14 mm. Average ΔSUVs were 6-8% with dPET values being higher for all three SUV-parameters (p < 0.001). ΔSUVmax was significantly higher than ΔSUVmean (8% vs. 6%, p = 0.002) and than ΔSUVpeak (8% vs. 7%, p = 0.03). Repeatability coefficients across individual lesions were 27% (ΔSUVmean and ΔSUVpeak) and 33% (ΔSUVmax) (p < 0.001). Conclusions: With EARL-accredited conventional and digital PET, we found a limited SUV variability with average differences up to 8%. Furthermore, only a limited number of lesions showed a SUV difference of more than 30%. These findings indicate that EARL standardisation works. Trial registration: This prospective study was registered on the 31th of October 2017 at ClinicalTrials.cov. URL: https://clinicaltrials.gov/ct2/show/NCT03457506?id=03457506&rank=1.
- 1 February 2017
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 24 (1) , 212-223
Sequential SPECT/CT imaging for detection of coronary artery disease in a large cohort: evaluation of the need for additional imaging and radiation exposure
- 1 February 2017
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 24 (1) , 212-223
Sequential SPECT/CT imaging for detection of coronary artery disease in a large cohort: evaluation of the need for additional imaging and radiation exposure
- Open Access
- 31 January 2017
- Published by Springer Nature in EJNMMI Physics
- Vol. 4 (1) , 1-6
Digital PET compliance to EARL accreditation specifications
Our aim was to evaluate if a recently introduced TOF PET system with digital photon counting technology (Philips Healthcare), potentially providing an improved image quality over analogue systems, can fulfil EANM research Ltd (EARL) accreditation specifications for tumour imaging with FDG-PET/CT. We have performed a phantom study on a digital TOF PET system using a NEMA NU2-2001 image quality phantom with six fillable spheres. Phantom preparation and PET/CT acquisition were performed according to the European Association of Nuclear Medicine (EANM) guidelines. We made list-mode ordered-subsets expectation maximization (OSEM) TOF PET reconstructions, with default settings, three voxel sizes (4 × 4 × 4 mm3, 2 × 2 × 2 mm3 and 1 × 1 × 1 mm3) and with/without point spread function (PSF) modelling. On each PET dataset, mean and maximum activity concentration recovery coefficients (RCmean and RCmax) were calculated for all phantom spheres and compared to EARL accreditation specifications. The RCs of the 4 × 4 × 4 mm3 voxel dataset without PSF modelling proved closest to EARL specifications. Next, we added a Gaussian post-smoothing filter with varying kernel widths of 1–7 mm. EARL specifications were fulfilled when using kernel widths of 2 to 4 mm. TOF PET using digital photon counting technology fulfils EARL accreditation specifications for FDG-PET/CT tumour imaging when using an OSEM reconstruction with 4 × 4 × 4 mm3 voxels, no PSF modelling and including a Gaussian post-smoothing filter of 2 to 4 mm.
- 31 January 2017
- Published by Springer Nature in EJNMMI Physics
- Vol. 4 (1) , 1-6
Open AccessDigital PET compliance to EARL accreditation specifications
Our aim was to evaluate if a recently introduced TOF PET system with digital photon counting technology (Philips Healthcare), potentially providing an improved image quality over analogue systems, can fulfil EANM research Ltd (EARL) accreditation specifications for tumour imaging with FDG-PET/CT. We have performed a phantom study on a digital TOF PET system using a NEMA NU2-2001 image quality phantom with six fillable spheres. Phantom preparation and PET/CT acquisition were performed according to the European Association of Nuclear Medicine (EANM) guidelines. We made list-mode ordered-subsets expectation maximization (OSEM) TOF PET reconstructions, with default settings, three voxel sizes (4 × 4 × 4 mm3, 2 × 2 × 2 mm3 and 1 × 1 × 1 mm3) and with/without point spread function (PSF) modelling. On each PET dataset, mean and maximum activity concentration recovery coefficients (RCmean and RCmax) were calculated for all phantom spheres and compared to EARL accreditation specifications. The RCs of the 4 × 4 × 4 mm3 voxel dataset without PSF modelling proved closest to EARL specifications. Next, we added a Gaussian post-smoothing filter with varying kernel widths of 1–7 mm. EARL specifications were fulfilled when using kernel widths of 2 to 4 mm. TOF PET using digital photon counting technology fulfils EARL accreditation specifications for FDG-PET/CT tumour imaging when using an OSEM reconstruction with 4 × 4 × 4 mm3 voxels, no PSF modelling and including a Gaussian post-smoothing filter of 2 to 4 mm.
- Open Access
- 29 September 2016
- Published by Springer Nature in EJNMMI Physics
- Vol. 3 (1) , 22
Technical note: how to determine the FDG activity for tumour PET imaging that satisfies European guidelines
For tumour imaging with PET, the literature proposes to administer a patient-specific FDG activity that depends quadratically on a patient’s body weight. However, a practical approach on how to implement such a protocol in clinical practice is currently lacking. We aimed to provide a practical method to determine a FDG activity formula for whole-body PET examinations that satisfies both the EANM guidelines and this quadratic relation. We have developed a methodology that results in a formula describing the patient-specific FDG activity to administer. A PET study using the NEMA NU-2001 image quality phantom forms the basis of our method. This phantom needs to be filled with 2.0 and 20.0 kBq FDG/mL in the background and spheres, respectively. After a PET acquisition of 10 min, a reconstruction has to be performed that results in sphere recovery coefficients (RCs) that are within the specifications as defined by the EANM Research Ltd (EARL). By performing reconstructions based on shorter scan durations, the minimal scan time per bed position (T min) needs to be extracted using an image coefficient of variation (COV) of 15 %. At T min, the RCs should be within EARL specifications as well. Finally, the FDG activity (in MBq) to administer can be described by A = c ⋅ w 2 ⋅ T min t $$ A=c \cdot {w}^2\cdot \frac{T_{\min }}{t} $$ with c a constant that is typically 0.0533 (MBq/kg2), w the patient’s body weight (in kg), and t the scan time per bed position that is chosen in a clinical setting (in seconds). We successfully demonstrated this methodology using a state-of-the-art PET/CT scanner. We provide a practical method that results in a formula describing the FDG activity to administer to individual patients for whole-body PET examinations, taking into account both the EANM guidelines and a quadratic relation between FDG activity and patient’s body weight. This formula is generally applicable to any PET system, using a specified image reconstruction and scan time per bed position.- 29 September 2016
- Published by Springer Nature in EJNMMI Physics
- Vol. 3 (1) , 22
Open AccessTechnical note: how to determine the FDG activity for tumour PET imaging that satisfies European guidelines
For tumour imaging with PET, the literature proposes to administer a patient-specific FDG activity that depends quadratically on a patient’s body weight. However, a practical approach on how to implement such a protocol in clinical practice is currently lacking. We aimed to provide a practical method to determine a FDG activity formula for whole-body PET examinations that satisfies both the EANM guidelines and this quadratic relation. We have developed a methodology that results in a formula describing the patient-specific FDG activity to administer. A PET study using the NEMA NU-2001 image quality phantom forms the basis of our method. This phantom needs to be filled with 2.0 and 20.0 kBq FDG/mL in the background and spheres, respectively. After a PET acquisition of 10 min, a reconstruction has to be performed that results in sphere recovery coefficients (RCs) that are within the specifications as defined by the EANM Research Ltd (EARL). By performing reconstructions based on shorter scan durations, the minimal scan time per bed position (T min) needs to be extracted using an image coefficient of variation (COV) of 15 %. At T min, the RCs should be within EARL specifications as well. Finally, the FDG activity (in MBq) to administer can be described by A = c ⋅ w 2 ⋅ T min t $$ A=c \cdot {w}^2\cdot \frac{T_{\min }}{t} $$ with c a constant that is typically 0.0533 (MBq/kg2), w the patient’s body weight (in kg), and t the scan time per bed position that is chosen in a clinical setting (in seconds). We successfully demonstrated this methodology using a state-of-the-art PET/CT scanner. We provide a practical method that results in a formula describing the FDG activity to administer to individual patients for whole-body PET examinations, taking into account both the EANM guidelines and a quadratic relation between FDG activity and patient’s body weight. This formula is generally applicable to any PET system, using a specified image reconstruction and scan time per bed position. - 11 April 2016
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 10 (4) , 327-329
Visual estimation of coronary calcium on computed tomography for attenuation correction
- 11 April 2016
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 10 (4) , 327-329
Visual estimation of coronary calcium on computed tomography for attenuation correction
- Open Access
- 12 November 2015
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 32 (3) , 531-538
A practical approach for a patient-tailored dose protocol in coronary CT angiography using prospective ECG triggering
To derive and validate a practical patient-specific dose protocol to obtain an image quality, expressed by the image noise, independent of patients’ size and a better radiation dose justification in coronary CT angiography (CCTA) using prospective ECG triggering. 43 patients underwent clinically indicated CCTA. The image noise, defined as the standard deviation of pixel attenuation values in a homogeneous region in the liver, was determined in all scans. Subsequently, this noise was normalized to the radiation exposure. Next, three patient-specific parameters, body weight, body mass index and mass per length (MPL), were tested for the best correlation with normalized image noise. From these data, a new dose protocol to provide a less variable image noise was derived and subsequently validated in 84 new patients. The normalized image noise increased for heavier patients for all patients’ specific parameters (p < 0.001). MPL correlated best with the normalized image noise and was selected for dose protocol optimization. This new protocol resulted in image noise levels independent of patients’ MPL (p = 0.28). A practical method to obtain CCTA images with noise levels independent of patients’ MPL was derived and validated. It results in a less variable image quality and better radiation exposure justification and can also be used for CT scanners from other vendors.
- 12 November 2015
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 32 (3) , 531-538
Open AccessA practical approach for a patient-tailored dose protocol in coronary CT angiography using prospective ECG triggering
To derive and validate a practical patient-specific dose protocol to obtain an image quality, expressed by the image noise, independent of patients’ size and a better radiation dose justification in coronary CT angiography (CCTA) using prospective ECG triggering. 43 patients underwent clinically indicated CCTA. The image noise, defined as the standard deviation of pixel attenuation values in a homogeneous region in the liver, was determined in all scans. Subsequently, this noise was normalized to the radiation exposure. Next, three patient-specific parameters, body weight, body mass index and mass per length (MPL), were tested for the best correlation with normalized image noise. From these data, a new dose protocol to provide a less variable image noise was derived and subsequently validated in 84 new patients. The normalized image noise increased for heavier patients for all patients’ specific parameters (p < 0.001). MPL correlated best with the normalized image noise and was selected for dose protocol optimization. This new protocol resulted in image noise levels independent of patients’ MPL (p = 0.28). A practical method to obtain CCTA images with noise levels independent of patients’ MPL was derived and validated. It results in a less variable image quality and better radiation exposure justification and can also be used for CT scanners from other vendors.
- Open Access
- 9 September 2015
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 23 (1) , 134-142
Development and validation of a patient-tailored dose regime in myocardial perfusion imaging using conventional SPECT
- 9 September 2015
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 23 (1) , 134-142
Open AccessDevelopment and validation of a patient-tailored dose regime in myocardial perfusion imaging using conventional SPECT
- 1 December 2014
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 21 (6) , 1158-1167
Development and validation of a patient-tailored dose regime in myocardial perfusion imaging using CZT-SPECT
- 1 December 2014
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 21 (6) , 1158-1167
Development and validation of a patient-tailored dose regime in myocardial perfusion imaging using CZT-SPECT
- 1 November 2014
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 33 (6) , 346-351
El regadenosón como nuevo agente de estrés para la adquisición de imágenes SPECT de perfusión miocárdica. Experiencia inicial en Holanda
- 1 November 2014
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 33 (6) , 346-351
El regadenosón como nuevo agente de estrés para la adquisición de imágenes SPECT de perfusión miocárdica. Experiencia inicial en Holanda